Results 31 to 40 of about 23,544 (244)

An AMPK activator as a therapeutic option for congenital nephrogenic diabetes insipidus

open access: yesJCI Insight, 2021
Nephrogenic diabetes insipidus (NDI) patients produce large amounts of dilute urine. NDI can be congenital, resulting from mutations in the type-2 vasopressin receptor (V2R), or acquired, resulting from medications such as lithium. There are no effective
J. Klein   +6 more
semanticscholar   +1 more source

Molecular Characterization of an Aquaporin−2 Mutation Causing Nephrogenic Diabetes Insipidus

open access: yesFrontiers in Endocrinology, 2021
The aquaporin 2 (AQP2) plays a critical role in water reabsorption to maintain water homeostasis. AQP2 mutation leads to nephrogenic diabetes insipidus (NDI), characterized by polyuria, polydipsia, and hypernatremia.
Qian Li   +10 more
semanticscholar   +1 more source

Incidence, severity and prognosis associated with hypernatremia in dogs and cats. [PDF]

open access: yes, 2015
BackgroundHypernatremia has been associated with substantial morbidity and death in human patients. The incidence and importance of hypernatremia in dogs and cats has not been determined.Hypothesis/objectivesTo describe the incidence of and prognosis ...
Epstein, SE, Hopper, K, Ueda, Y
core   +2 more sources

The combined effect of hypomagnesemia and hypokalemia inducing nephrogenic diabetes insipidus in a patient with type 1 diabetes mellitus

open access: yesClinical Case Reports, 2021
Nephrogenic diabetes insipidus (NDI) is rarely considered against more common differentials such as diabetes mellitus in patients presenting with polydipsia and polyuria.
Esmail Sangey   +2 more
doaj   +1 more source

Signaling Modification by GPCR Heteromer and Its Implication on X-Linked Nephrogenic Diabetes Insipidus [PDF]

open access: yes, 2016
published_or_final_versio
Chow, BKC   +3 more
core   +1 more source

A case of primary aldosteronism combined with acquired nephrogenic diabetes insipidus

open access: yesKidney Research and Clinical Practice, 2014
Aldosterone-producing adrenal adenoma can induce various clinical manifestations as a result of chronic exposure to aldosterone. We report a rare case of a 37-year-old man who complained of general weakness and polyuria. He was diagnosed with aldosterone-
Kitae Kim   +4 more
doaj   +1 more source

Impact of the 2016 Kumamoto earthquake on patients with nephrogenic diabetes insipidus and preparations for the future

open access: yesClinical Case Reports, 2021
Patients with nephrogenic diabetes insipidus should establish a support network system by contacting the government to ensure that water can be preferentially obtained in the event of a disaster and create and carry a medical alert card.
Hiroshi Tamura   +5 more
doaj   +1 more source

Altered agonist sensitivity of a mutant V2 receptor suggests a novel therapeutic strategy for nephrogenic diabetes insipidus. [PDF]

open access: yes, 2014
Loss of function mutations of the type 2 vasopressin receptor (V2R) in kidney can lead to nephrogenic diabetes insipidus (NDI). We studied a previously described, but uncharacterized mutation of V2R (N321K missense mutation) of an NDI patient.
Balla, András   +5 more
core   +1 more source

Receptores acoplados à proteína G: implicações para a fisiologia e doenças endócrinas [PDF]

open access: yes, 2001
The majority of polypeptide hormones and even extracellular calcium signal their target cells through G protein-coupled receptors (GPCRs). Recently, many mutations have been both identified and associated with several endocrine disorders, such as ...
Hauache, Omar M.
core   +3 more sources

Diagnosis, Treatment, and Outcomes in Children With Congenital Nephrogenic Diabetes Insipidus: A Pediatric Nephrology Research Consortium Study

open access: yesFrontiers in Pediatrics, 2020
Background and Objectives: Congenital or primary nephrogenic diabetes insipidus (NDI) is a rare genetic disorder that severely impairs renal concentrating ability, resulting in massive polyuria.
Cynthia D'Alessandri-Silva   +18 more
semanticscholar   +1 more source

Home - About - Disclaimer - Privacy